If you may have been exposed to mpox, JYNNEOS post-exposure prophylaxis works best when started within 4 days (and may still help if given up to 14 days). If you develop a new, unusual rash after a relevant exposure window, contact a clinician promptly to ask about mpox PCR testing.
A May 29, 2026 executive order directs CDC and ACIP to review how childhood vaccines are organized and to update guidance using “best practices”—while aiming to preserve access to vaccines already available in the U.S. Here’s what families and schools can do today to stay on track, understand “core” versus shared decision-making vaccines, and reduce appointment and coverage confusion.
If you have a Hintermann Series H3 total ankle replacement—or are considering one—FDA says the long-term risk of device failure and possible revision surgery is higher than expected. FDA advises keeping follow-ups and contacting your health care provider promptly if specific new or worsening symptoms appear.
A July 1, 2026 randomized trial (CICERO) tested goal-oriented cognitive rehabilitation for long COVID “brain fog.” It improved participants’ personalized functional goal attainment at 3 months and maintained the advantage at 6 months. But the trial did not show clear improvement in fatigue/post-exertional malaise (PEM) or several other symptom domains.
CDC says cyclosporiasis cases have increased in the U.S. Prolonged watery diarrhea can last weeks, and routine stool testing may miss Cyclospora. Here’s what to ask about Cyclospora-specific testing, what results can mean, and what CDC says about treatment with TMP-SMX and key safety cautions.
CMS enforcement of updated hospital price transparency requirements starts April 1, 2026. Here’s what hospitals must post, what “standard charges” mean, what they don’t tell you about your bill, and how to use the files for scheduled care.
If you ate the recalled Clover Hill Dairy soft ricotta/requesón, CDC says listeria symptoms can start the same day or take weeks—up to 10 weeks. Pregnancy and other high-risk groups should call right away if symptoms appear.
A CDC snapshot (as of May 23, 2026) shows many more children reported getting a seasonal flu vaccine than a 2025–26 COVID-19 vaccine. Here’s a calm, step-by-step catch-up plan and how families can use the VFC program if cost is a barrier.
On June 12, 2026, the FDA approved an ODACTRA (house dust mite) sublingual immunotherapy label update adding “dizziness” and “rash” to postmarketing adverse-reaction wording. Here’s what that means for allergy symptom monitoring, who should not use ODACTRA, and when to stop and get urgent help.
FDA’s VRBPAC reviewed investigational Moderna’s mRNA flu vaccine candidate (mFlusiva/mRNA-1010) for adults 50+. The Phase 3 signal showed a relative efficacy benefit versus a standard-dose comparator, but short-term reactions were more common than in the comparator. Key uncertainties—like limited data in the frail/high-risk older adults and limited duration-of-protection evidence—remain. CDC guidance is still to get an approved flu vaccine now rather than waiting.
CMS issued an interim final rule for Medicaid “community engagement” (80 hours/month) that states generally must start by Jan. 1, 2027. Here’s who is subject, what can count toward the hours, which exemptions—including medical frailty—may apply, and what to do if your state can’t verify compliance.
FDA posted a May 26, 2026 voluntary medical device correction for certain Omnipod 5, Omnipod DASH, and Omnipod Eros (insulin management system) pod lots due to a manufacturing issue that could cause insulin under-delivery. Here’s how to check your pod lot and when DKA warning signs mean you need emergency care.
EPA updated its home asthma-trigger guidance on July 6, 2026. Use this practical room-by-room routine to reduce exposure to wood smoke, dust mites, mold/moisture, pets, and irritant chemicals—plus clear danger signs for when to get emergency help.
CMS says enforcement of updated hospital price-transparency requirements starts April 1, 2026. For rural patients, CMS’s enforcement-activity dataset can help you see where compliance reviews happened and what CMS did—but it won’t tell you your exact out-of-pocket bill.
Starting July 1, 2026, eligible Medicare Part D beneficiaries can access certain GLP-1 weight-loss medicines through the Medicare GLP-1 Bridge at a predictable $50/month copay, through December 31, 2027. Eligibility depends on age, BMI/health conditions, and whether someone already gets a GLP-1 through their Part D plan.
FDA warns that the TRUE METRIX “E-5” message can mean either a very high blood sugar event (over 600 mg/dL) or a test-strip error. Don’t guess—switch to an alternative glucose-testing method if possible, keep testing until you have an alternative, and contact your clinician right away if E-5 shows up with symptoms of low or high blood sugar.
FDA has advised manufacturers to use an updated, monovalent 2026–2027 COVID-19 vaccine formula targeting a JN.1-lineage variant called XFG for use in fall 2026. Here’s what that “strain/formula” decision does—and what stays the same—plus practical steps for families using CDC’s risk-based vaccine guidance.
A good home blood pressure reading depends on using a validated upper-arm cuff, the right cuff size, correct positioning, and repeat measurements. Here’s how—and when a very high reading needs urgent help.
CMS says enforcement of updated hospital price transparency requirements begins April 1, 2026. In its June 26, 2026 FAQs, CMS also clarifies how hospitals should encode “allowed amount” percentile elements in the machine-readable file and how to ensure automated download access—while reporting shows CMS warning activity continuing at scale.
FDA says BD is recalling specific lots of ChloraPrep™ Clear applicators due to a potential for Aspergillus contamination. If you recently had surgery or an IV/catheter—especially if you’re immunocompromised—here’s what to ask and what symptoms to watch for.
The FDA updated its safety communication on July 2, 2026, confirming a Class I recall for certain Insulet Omnipod pods. If you use Omnipod, check the pod lot, stop using pods from affected lots, change your pod immediately if yours may be affected, monitor glucose closely, and follow your ketone plan—especially if high blood sugar doesn’t improve.
CDC’s “Activity Levels” and “Illness Severity” indicators are designed to show community trends in respiratory virus spread and hospital burden. This guide explains what the levels can—and can’t—tell you, how wastewater fits in, and what practical “protect more” steps families and schools can take without panic.
End of content
End of content